Clinical Neuromuscular Pathology Certification Examination Committee Contributors
Mazen Mohammad Dimachkie, MD, Chair, University of Kansas Medical Center
Disclosures: Received personal compensation for consulting services provided to: ArgenX, Catalyst, Cello, Covance, CSL-Behring, EcoR1, Kezar, Momenta, NuFactor, Octapharma, RaPharma/UCB, RMS Medical, Sanofi Genzyme, Shire Takeda, Scholar Rock, Spark Therapeutics, Third Rock and UCB Biopharma; received research grants or contracts from Alexion, Alnylam Pharmaceuticals, Amicus, Biomarin, Bristol-Myers Squibb, Catalyst, Corbus, CSL-Behring, FDA/OOPD, GlaxoSmithKline, Genentech, Grifols, Mitsubishi Tanabe Pharma, MDA, NIH, Novartis, Octapharma, Orphazyme, Ra Pharma/UCB, Sanofi Genzyme, Sarepta Therapeutics, Shire Takeda, Spark Therapeutics, UCB Biopharma, Viromed/Healixmith and TMA. Compensation/research funded in part by Pharmaceutical.
Michelle Lynn Mauermann, MD, Vice Chair, Mayo Clinic – Rochester
Disclosures: Receives research support from Alnylam, IONIS, and EIDOS for amyloid clinical trials.
Robert C. Bucelli, MD, PhD, Washington University School of Medicine in St. Louis
Disclosures: Holds equity in Neuroquestions.com, a board review website, and receives K-1 income from site on annual basis. Received compensation for serving on advisory board and as a steering committee member for Biogen; provided review of case for a defense lawyer as an expert witness.
Ahmed Mohamed Attia El-Dokla, MD, Neuromuscular Clinic at Upstate Bone & Joint
Disclosures: Nothing to disclose.
Shalini Mahajan, MD, Cedars-Sinai Medical Center
Disclosures: Nothing to disclose.
Raghav Govindarajan, MD, St. Elizabeth Medical Group, Illinois
Disclosures: Received compensation from Alexion (consulting and speaking), UCB (consulting), Biohaven (consulting and speaking), MT pharma (consulting and speaking), Catalyst (consulting and speaking), Argenx (consulting), Roche (consulting), Sarepta (consulting), Amicus (consulting); received compensation for serving on advisory boards for: MGFA, MGA, ALSA. Served in editorial role for Alexion and UCB, and as researcher for Band of Hope foundation, with funding for clinical trial poly MVA in ALS.
Margherita Milone, MD, PhD, Mayo Clinic – Rochester
Disclosures: Received internal research funding for research at Mayo Clinic.
Aziz Shaibani, MD, Nerve and Muscle Center of Texas
Disclosures: Nothing to disclose.
Anthony A. Amato, MD, Brigham and Women's Hospital
Disclosures: Received fees while serving as a consultant/medical advisory board for Johnson & Johnson, Argenx, and Serono; received compensation and/or research funding through NIH grant.
Mohamed Kazamel, MD, University of Alabama at Birmingham
Disclosures: Received fees for consulting/speaking for Alnylam Pharmaceuticals; received research funding from NIH Porphyria and Rare Disease Consortium.